Cardimax®

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.005950.04.15
Date of registration and renewal:24.04.2015
Dosage form: & nbspTablets weighing 0.3 g, 0.5 g; capsules of 0.3 g.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes BAA sources of antioxidant substances and substances that affect energy metabolism Supplements that support the function of the cardiovascular system Supplements that promote the normalization of lipid metabolism
Composition: & nbspComposition (tablet): lactose, vitamin premix standardized in composition (vitamins E, C, B1, B2, B12, folic acid, calcium pantothenate, niacin, biotin), microcrystalline cellulose carrier, Baikal skullcap root extract, hawthorn extract, root extract valerian, anti-scoring agents (aerosil, calcium or magnesium stearate).

Ingredients (capsule): Vitamin premix premix (vitaimins E, C, B1, B2, B12, folic acid, calcium pantothenate, niacin, biotin), lactose, extract of the roots of the Baikal skullcap, hawthorn extract, valerian root extract, anti-caking agent (aerosil), capsule (gelatin).
Scope: & nbspDFor realization to the population as a biologically active food additive - a source of flavonoids, an additional source of vitamins E, C, B1, B2, B6, B12, folic acid, calcium pantothenate, niacin, biotin.
Suggested Usage: & nbspAT1 tablet or 1 capsule 2 times a day with meals.Duration of admission 4 weeks. Break between courses for 4 weeks.
Contraindications:ANDndividualnaya intolerance of components of dietary supplements, pregnancy, breastfeeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:24 months.
Storage conditions:Store in a dry place, protected from light, out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.32.003.Е.002864.02.15 of 10.02.2015, the expert opinion of the Research Institute of Nutrition of RAMS № 72 / Э-3272 / б-04 of 02.12.2004; the protocol of the Center for Analysis of the Quality of Biotechnology Products and BAD OOO BITEX №845 / 1585 of 03.12.2014.
Recipient:Alina Pharma, OOOAlina Pharma, OOO Russian Federation
Information update date: & nbsp21.06.2016
Instructions
Up